Wu Y, Yang Y Z, Koenig R J
Division of Endocrinology and Metabolism, University of Michigan Medical Center, Ann Arbor 48109-0678, USA.
Mol Endocrinol. 1998 Oct;12(10):1542-50. doi: 10.1210/mend.12.10.0178.
Heterodimerization between thyroid hormone receptors (TRs) and retinoid X receptors (RXRs) is mediated by a weak dimerization interface within the DNA- binding domains (DBDs) and a strong interface within the C-terminal ligand- binding domains of the receptors. Previous studies have shown that the conserved ninth heptad in the TR ligand-binding domain appears to play a critical role in heterodimerization with RXR. However, despite lacking the full ninth heptad, TR variant alpha2 (TRv alpha2) can heterodimerize with RXR on specific direct repeat response elements, but not on palindromic elements or in solution. Two possibilities may account for TRv alpha2-RXR heterodimerization on direct repeats. First, the DBD of TRv alpha2 may play a critical role in heterodimerization with RXR. Second, a specific sequence within the unique C terminus of TRv alpha2 may promote the formation of TRv alpha2-RXR heterodimers. In this study, we used receptor chimeras in which the DBD of RXR was replaced by either the TR DBD or an unrelated DBD from the metalloregulatory transcription factor AMT1 to address the role of the DBD dimerization interface in TRv alpha2-RXR heterodimerization. Gel mobility shift analyses showed that whereas TR alpha1 formed heterodimers with these chimeras, TRv alpha2 failed to do so. Deletion of the unique C terminus of TRv alpha2 had only a marginal effect on heterodimerization with RXR. Mutations within the DBD dimerization interface abolished heterodimerization of full-length TRv alpha2 with RXR but only marginally affected heterodimerization of full-length TR alpha1 with RXR. These data support the hypothesis that the TR-RXR DBD dimerization interface plays a critical role in TRv alpha2-RXR heterodimerization. Additional data show that the amino acid residues that make direct TR-RXR contacts within the DBDs also may play a role in receptor monomer binding to DNA, since mutations within these residues severely impair this interaction.
甲状腺激素受体(TRs)与视黄酸X受体(RXRs)之间的异源二聚化由DNA结合结构域(DBDs)内的弱二聚化界面以及受体C端配体结合结构域内的强界面介导。先前的研究表明,TR配体结合结构域中保守的第九个七肽似乎在与RXR的异源二聚化中起关键作用。然而,尽管缺乏完整的第九个七肽,TR变体α2(TRvα2)仍可在特定的直接重复反应元件上与RXR异源二聚化,但在回文元件上或溶液中则不能。有两种可能性可以解释TRvα2与RXR在直接重复序列上的异源二聚化。第一,TRvα2的DBD可能在与RXR的异源二聚化中起关键作用。第二。TRvα2独特C端内的特定序列可能促进TRvα2-RXR异源二聚体的形成。在本研究中,我们使用受体嵌合体,其中RXR的DBD被TR DBD或金属调节转录因子AMT1的无关DBD取代,以研究DBD二聚化界面在TRvα2-RXR异源二聚化中的作用。凝胶迁移率变动分析表明,虽然TRα1与这些嵌合体形成了异源二聚体,但TRvα2却不能。删除TRvα2的独特C端对与RXR的异源二聚化只有轻微影响。DBD二聚化界面内的突变消除了全长TRvα2与RXR的异源二聚化,但仅轻微影响全长TRα1与RXR的异源二聚化。这些数据支持这样的假设,即TR-RXR DBD二聚化界面在TRvα2-RXR异源二聚化中起关键作用。其他数据表明,在DBDs内直接进行TR-RXR接触的氨基酸残基也可能在受体单体与DNA的结合中起作用,因为这些残基内的突变会严重损害这种相互作用。